Results 81 to 90 of about 17,026 (191)

Manufacturing and clinical applications of non‐CAR‐T immune effector cells

Transfusion, EarlyView.
Thane Kubik, Theodros Mamo, David H. McKenna   +2 more
wiley   +1 more source

[Search for HHV-8 associated diseases reservoir and spread paths of HHV-8 in Russia].

Voprosy virusologii, 2005
Summarized in the paper are study results of human herpesvirus type 8 (HHV-8) and of its association with Kaposi's sarcoma (KS). The data obtained denotes that the share of individuals producing the antibodies to HHV-8 in a majority of studied patients was low and ranged form 0 to 5.5%, which is indicative of a low degree of the virus spread in ...
V E, Gurtsevich, E L, Kadyrova, V A, Chernova, L V, Demidov, B M, Gruzdev, A, Gessain, L S, Iakovleva   +6 more
openaire   +1 more source

Serological study of the frequency of human herpesvirus-8 in patients with liver cirrhosis [PDF]

Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām
Introduction:  Various factors, including viruses, are involved in developing liver cirrhosis. Although the association of human herpesvirus-8 (HHV-8) with liver cirrhosis remains poorly understood, a significant increase in the titer of antibodies ...
Ava Hashempour, Zahra Musavi, Javad Moayedi   +2 more
doaj  

First survey for detecting the presence of human herpesvirus 8 infection (HHV-8) in Maputo, Mozambique

Brazilian Journal of Infectious Diseases
Human herpesvirus 8 (HHV-8), the etiological agent of Kaposi's sarcoma (KS), is endemic in parts of the sub-Saharan, and KS has increased concomitantly with the HIV/AIDS epidemic. In Mozambique (MZ), no data concerning HHV-8 infection was available, thus
Adele Caterino-de-Araujo, Rolanda Carmen Rafael Manuel, Rosana Del Bianco, Elizabeth Santos-Fortuna, Mariana Cavalheiro Magri, Joyce Matie Kinoshita Silva, Rui Bastos   +6 more
doaj   +1 more source

No Evidence of Human Herpesvirus 8 among Iranian Patients Infected with HIV

Iranian Journal of Public Health, 2016
Background: Kaposi’s sarcoma is a vascular malignancy, which frequently occurs among immunocompromised individuals such as transplant recipients and patients with acquired immunodeficiency syndrome.
Amitis RAMEZANI, Elham SABOORI, Kayhan AZADMANESH, Minoo MOHRAZ, Monireh KAZEMIMANESH, Afsaneh KARAMI, Mohammad BANIFAZL, Hanieh GOLCHEHREGAN, Arezoo AGHAKHANI   +8 more
doaj  

HHV-8, Transfusion, and Mortality [PDF]

Journal of Infectious Diseases, 2012
openaire   +2 more sources

Human Herpesvirus 8 (HHV-8) Staining: A Savior in Early Kaposi Sarcoma. [PDF]

Cureus, 2023
Siddiqui F, Al Ameer MA, Al-Khalaf J, Al-Marzooq Y, Al Ameer A.   +4 more
europepmc   +1 more source

Primary Effusion Lymphoma, Multicentric Castleman's Disease, and Kaposi's Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report. [PDF]

Medicina (Kaunas), 2023
Caballero JC, Pardo L, Rodriguez-Pinilla MS, Piris MA, Alvarez B, Solan L, Cornago J, Lopez-Lorenzo JL, Llamas P, Cordoba R, Lopez-Garcia A.   +10 more
europepmc   +1 more source

Transformation of HHV-8-negative idiopathic multicentric Castleman disease into diffuse large B-cell lymphoma: A case report from Nepal. [PDF]

Clin Case Rep, 2023
Gupta A, Anand A, Hussain SH, Shah R, Ranjan R, Subedi V, Baral A, Mishra A, Pradhan A, Dulal S.   +9 more
europepmc   +1 more source

Harnessing Redox Disruption to Treat Human Herpesvirus 8 (HHV-8) Related Malignancies. [PDF]

Antioxidants (Basel), 2022
Gothland A, Jary A, Grange P, Leducq V, Beauvais-Remigereau L, Dupin N, Marcelin AG, Calvez V.   +7 more
europepmc   +1 more source